nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—CYP2B6—Thiotepa—sarcoma	0.208	0.27	CbGbCtD
Mexiletine—CYP2E1—Dacarbazine—sarcoma	0.117	0.152	CbGbCtD
Mexiletine—CYP2E1—Mitoxantrone—sarcoma	0.0907	0.118	CbGbCtD
Mexiletine—CYP1A2—Dacarbazine—sarcoma	0.0676	0.0878	CbGbCtD
Mexiletine—CYP3A4—Thiotepa—sarcoma	0.0639	0.083	CbGbCtD
Mexiletine—CYP2E1—Etoposide—sarcoma	0.0572	0.0743	CbGbCtD
Mexiletine—CYP2B6—Doxorubicin—sarcoma	0.0385	0.05	CbGbCtD
Mexiletine—CYP1A2—Etoposide—sarcoma	0.0331	0.043	CbGbCtD
Mexiletine—CYP3A4—Mitoxantrone—sarcoma	0.0275	0.0357	CbGbCtD
Mexiletine—CYP3A4—Vincristine—sarcoma	0.0189	0.0246	CbGbCtD
Mexiletine—CYP2D6—Doxorubicin—sarcoma	0.0186	0.0241	CbGbCtD
Mexiletine—CYP3A4—Etoposide—sarcoma	0.0173	0.0225	CbGbCtD
Mexiletine—CYP3A4—Doxorubicin—sarcoma	0.0118	0.0154	CbGbCtD
Mexiletine—SCN9A—L1CAM interactions—EZR—sarcoma	0.00127	0.0284	CbGpPWpGaD
Mexiletine—SCN4A—L1CAM interactions—EZR—sarcoma	0.00117	0.0261	CbGpPWpGaD
Mexiletine—SCN2A—L1CAM interactions—EZR—sarcoma	0.00117	0.0261	CbGpPWpGaD
Mexiletine—SCN10A—L1CAM interactions—EZR—sarcoma	0.00112	0.0251	CbGpPWpGaD
Mexiletine—SCN5A—L1CAM interactions—EZR—sarcoma	0.00079	0.0177	CbGpPWpGaD
Mexiletine—AHR—myometrium—sarcoma	0.000786	0.0667	CbGeAlD
Mexiletine—AHR—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	0.000748	0.0167	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	0.000727	0.0163	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.000722	0.0161	CbGpPWpGaD
Mexiletine—AHR—seminal vesicle—sarcoma	0.00071	0.0603	CbGeAlD
Mexiletine—SCN5A—Cardiac Progenitor Differentiation—CXCR4—sarcoma	0.000704	0.0157	CbGpPWpGaD
Mexiletine—CYP2E1—Folate-Alcohol and Cancer Pathway—CREB1—sarcoma	0.000684	0.0153	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—SRC—sarcoma	0.000653	0.0146	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	0.000653	0.0146	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	0.000636	0.0142	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—NRAS—sarcoma	0.000628	0.014	CbGpPWpGaD
Mexiletine—AHR—Adipogenesis—FOXO1—sarcoma	0.000607	0.0136	CbGpPWpGaD
Mexiletine—AHR—smooth muscle tissue—sarcoma	0.000594	0.0505	CbGeAlD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—MYC—sarcoma	0.000585	0.0131	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—EGFR—sarcoma	0.000572	0.0128	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	0.000572	0.0128	CbGpPWpGaD
Mexiletine—SCN2A—hematopoietic system—sarcoma	0.000546	0.0464	CbGeAlD
Mexiletine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000542	0.00312	CcSEcCtD
Mexiletine—Cardiac failure congestive—Epirubicin—sarcoma	0.000541	0.00311	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.00054	0.0121	CbGpPWpGaD
Mexiletine—Chest pain—Mitoxantrone—sarcoma	0.00054	0.00311	CcSEcCtD
Mexiletine—Arthralgia—Mitoxantrone—sarcoma	0.00054	0.00311	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.000539	0.0121	CbGpPWpGaD
Mexiletine—Paraesthesia—Thiotepa—sarcoma	0.000538	0.0031	CcSEcCtD
Mexiletine—Alopecia—Etoposide—sarcoma	0.000535	0.00308	CcSEcCtD
Mexiletine—Discomfort—Mitoxantrone—sarcoma	0.000533	0.00307	CcSEcCtD
Mexiletine—Somnolence—Thiotepa—sarcoma	0.000533	0.00307	CcSEcCtD
Mexiletine—Oedema—Vincristine—sarcoma	0.000531	0.00306	CcSEcCtD
Mexiletine—Dyspepsia—Thiotepa—sarcoma	0.000527	0.00304	CcSEcCtD
Mexiletine—SCN10A—hematopoietic system—sarcoma	0.000526	0.0447	CbGeAlD
Mexiletine—Hot flush—Epirubicin—sarcoma	0.000525	0.00302	CcSEcCtD
Mexiletine—Confusional state—Mitoxantrone—sarcoma	0.000522	0.003	CcSEcCtD
Mexiletine—Dermatitis exfoliative—Epirubicin—sarcoma	0.00052	0.00299	CcSEcCtD
Mexiletine—Menopausal symptoms—Epirubicin—sarcoma	0.00052	0.00299	CcSEcCtD
Mexiletine—Thrombocytopenia—Vincristine—sarcoma	0.00052	0.00299	CcSEcCtD
Mexiletine—Oedema—Mitoxantrone—sarcoma	0.000517	0.00298	CcSEcCtD
Mexiletine—Fatigue—Thiotepa—sarcoma	0.000517	0.00297	CcSEcCtD
Mexiletine—Dysgeusia—Etoposide—sarcoma	0.000516	0.00297	CcSEcCtD
Mexiletine—Hyperhidrosis—Vincristine—sarcoma	0.000514	0.00296	CcSEcCtD
Mexiletine—Fatigue—Dactinomycin—sarcoma	0.000513	0.00295	CcSEcCtD
Mexiletine—Constipation—Thiotepa—sarcoma	0.000512	0.00295	CcSEcCtD
Mexiletine—Pain—Thiotepa—sarcoma	0.000512	0.00295	CcSEcCtD
Mexiletine—AHR—cardiac atrium—sarcoma	0.000512	0.0435	CbGeAlD
Mexiletine—SCN5A—Cardiac Progenitor Differentiation—PDGFRA—sarcoma	0.000511	0.0114	CbGpPWpGaD
Mexiletine—AHR—uterus—sarcoma	0.00051	0.0433	CbGeAlD
Mexiletine—Shock—Mitoxantrone—sarcoma	0.000509	0.00293	CcSEcCtD
Mexiletine—Pain—Dactinomycin—sarcoma	0.000509	0.00293	CcSEcCtD
Mexiletine—Muscle spasms—Etoposide—sarcoma	0.000507	0.00292	CcSEcCtD
Mexiletine—Thrombocytopenia—Mitoxantrone—sarcoma	0.000507	0.00292	CcSEcCtD
Mexiletine—Cardiac failure congestive—Doxorubicin—sarcoma	0.000501	0.00288	CcSEcCtD
Mexiletine—Hyperhidrosis—Mitoxantrone—sarcoma	0.0005	0.00288	CcSEcCtD
Mexiletine—Hypotension—Vincristine—sarcoma	0.000496	0.00286	CcSEcCtD
Mexiletine—Feeling abnormal—Thiotepa—sarcoma	0.000494	0.00284	CcSEcCtD
Mexiletine—Feeling abnormal—Dactinomycin—sarcoma	0.00049	0.00282	CcSEcCtD
Mexiletine—Gastrointestinal pain—Thiotepa—sarcoma	0.00049	0.00282	CcSEcCtD
Mexiletine—Ill-defined disorder—Etoposide—sarcoma	0.000489	0.00282	CcSEcCtD
Mexiletine—Gastrointestinal pain—Dactinomycin—sarcoma	0.000486	0.0028	CcSEcCtD
Mexiletine—Hot flush—Doxorubicin—sarcoma	0.000486	0.00279	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Vincristine—sarcoma	0.000484	0.00279	CcSEcCtD
Mexiletine—Hypotension—Mitoxantrone—sarcoma	0.000484	0.00278	CcSEcCtD
Mexiletine—Menopausal symptoms—Doxorubicin—sarcoma	0.000481	0.00277	CcSEcCtD
Mexiletine—Dermatitis exfoliative—Doxorubicin—sarcoma	0.000481	0.00277	CcSEcCtD
Mexiletine—SCN9A—Axon guidance—EZR—sarcoma	0.000479	0.0107	CbGpPWpGaD
Mexiletine—Paraesthesia—Vincristine—sarcoma	0.000477	0.00275	CcSEcCtD
Mexiletine—Malaise—Etoposide—sarcoma	0.000476	0.00274	CcSEcCtD
Mexiletine—Abdominal pain—Thiotepa—sarcoma	0.000474	0.00273	CcSEcCtD
Mexiletine—Body temperature increased—Thiotepa—sarcoma	0.000474	0.00273	CcSEcCtD
Mexiletine—Leukopenia—Etoposide—sarcoma	0.000472	0.00272	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000471	0.00271	CcSEcCtD
Mexiletine—Abdominal pain—Dactinomycin—sarcoma	0.00047	0.00271	CcSEcCtD
Mexiletine—Body temperature increased—Dactinomycin—sarcoma	0.00047	0.00271	CcSEcCtD
Mexiletine—Paraesthesia—Mitoxantrone—sarcoma	0.000465	0.00267	CcSEcCtD
Mexiletine—Loss of consciousness—Etoposide—sarcoma	0.000464	0.00267	CcSEcCtD
Mexiletine—Ataxia—Epirubicin—sarcoma	0.000462	0.00266	CcSEcCtD
Mexiletine—Dyspnoea—Mitoxantrone—sarcoma	0.000461	0.00265	CcSEcCtD
Mexiletine—Somnolence—Mitoxantrone—sarcoma	0.00046	0.00265	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.000459	0.0103	CbGpPWpGaD
Mexiletine—Fatigue—Vincristine—sarcoma	0.000458	0.00264	CcSEcCtD
Mexiletine—SCN9A—tendon—sarcoma	0.000458	0.0389	CbGeAlD
Mexiletine—Convulsion—Etoposide—sarcoma	0.000457	0.00263	CcSEcCtD
Mexiletine—Dyspepsia—Mitoxantrone—sarcoma	0.000455	0.00262	CcSEcCtD
Mexiletine—Hypertension—Etoposide—sarcoma	0.000455	0.00262	CcSEcCtD
Mexiletine—Constipation—Vincristine—sarcoma	0.000454	0.00261	CcSEcCtD
Mexiletine—Pain—Vincristine—sarcoma	0.000454	0.00261	CcSEcCtD
Mexiletine—Liver function test abnormal—Epirubicin—sarcoma	0.000453	0.00261	CcSEcCtD
Mexiletine—SCN9A—Developmental Biology—MYOG—sarcoma	0.000451	0.0101	CbGpPWpGaD
Mexiletine—Dry skin—Epirubicin—sarcoma	0.00045	0.00259	CcSEcCtD
Mexiletine—Chest pain—Etoposide—sarcoma	0.000449	0.00258	CcSEcCtD
Mexiletine—AHR—tendon—sarcoma	0.000446	0.0379	CbGeAlD
Mexiletine—Fatigue—Mitoxantrone—sarcoma	0.000446	0.00257	CcSEcCtD
Mexiletine—Discomfort—Etoposide—sarcoma	0.000444	0.00255	CcSEcCtD
Mexiletine—Pain—Mitoxantrone—sarcoma	0.000443	0.00255	CcSEcCtD
Mexiletine—Constipation—Mitoxantrone—sarcoma	0.000443	0.00255	CcSEcCtD
Mexiletine—Hypersensitivity—Thiotepa—sarcoma	0.000441	0.00254	CcSEcCtD
Mexiletine—AHR—Adipogenesis—CREB1—sarcoma	0.000441	0.00986	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—EZR—sarcoma	0.00044	0.00985	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—EZR—sarcoma	0.00044	0.00985	CbGpPWpGaD
Mexiletine—Hypersensitivity—Dactinomycin—sarcoma	0.000438	0.00252	CcSEcCtD
Mexiletine—Gastrointestinal pain—Vincristine—sarcoma	0.000434	0.0025	CcSEcCtD
Mexiletine—Confusional state—Etoposide—sarcoma	0.000434	0.0025	CcSEcCtD
Mexiletine—AHR—bone marrow—sarcoma	0.000432	0.0367	CbGeAlD
Mexiletine—SCN5A—Cardiac Progenitor Differentiation—KDR—sarcoma	0.00043	0.00962	CbGpPWpGaD
Mexiletine—Asthenia—Thiotepa—sarcoma	0.00043	0.00247	CcSEcCtD
Mexiletine—Ataxia—Doxorubicin—sarcoma	0.000427	0.00246	CcSEcCtD
Mexiletine—Asthenia—Dactinomycin—sarcoma	0.000427	0.00246	CcSEcCtD
Mexiletine—Feeling abnormal—Mitoxantrone—sarcoma	0.000426	0.00245	CcSEcCtD
Mexiletine—SCN10A—Axon guidance—EZR—sarcoma	0.000425	0.0095	CbGpPWpGaD
Mexiletine—Dysphagia—Epirubicin—sarcoma	0.000424	0.00244	CcSEcCtD
Mexiletine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000423	0.00243	CcSEcCtD
Mexiletine—Thrombocytopenia—Etoposide—sarcoma	0.000421	0.00243	CcSEcCtD
Mexiletine—Body temperature increased—Vincristine—sarcoma	0.00042	0.00242	CcSEcCtD
Mexiletine—Abdominal pain—Vincristine—sarcoma	0.00042	0.00242	CcSEcCtD
Mexiletine—Liver function test abnormal—Doxorubicin—sarcoma	0.000419	0.00241	CcSEcCtD
Mexiletine—Dry skin—Doxorubicin—sarcoma	0.000416	0.0024	CcSEcCtD
Mexiletine—Hyperhidrosis—Etoposide—sarcoma	0.000416	0.00239	CcSEcCtD
Mexiletine—Pancreatitis—Epirubicin—sarcoma	0.000416	0.00239	CcSEcCtD
Mexiletine—SCN4A—Developmental Biology—MYOG—sarcoma	0.000415	0.00927	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—MYOG—sarcoma	0.000415	0.00927	CbGpPWpGaD
Mexiletine—Angina pectoris—Epirubicin—sarcoma	0.000413	0.00238	CcSEcCtD
Mexiletine—Diarrhoea—Thiotepa—sarcoma	0.00041	0.00236	CcSEcCtD
Mexiletine—Body temperature increased—Mitoxantrone—sarcoma	0.000409	0.00235	CcSEcCtD
Mexiletine—Abdominal pain—Mitoxantrone—sarcoma	0.000409	0.00235	CcSEcCtD
Mexiletine—SCN4A—tendon—sarcoma	0.000408	0.0347	CbGeAlD
Mexiletine—Diarrhoea—Dactinomycin—sarcoma	0.000407	0.00234	CcSEcCtD
Mexiletine—Hypotension—Etoposide—sarcoma	0.000402	0.00231	CcSEcCtD
Mexiletine—SCN10A—Developmental Biology—MYOG—sarcoma	0.0004	0.00894	CbGpPWpGaD
Mexiletine—Neutropenia—Epirubicin—sarcoma	0.000397	0.00228	CcSEcCtD
Mexiletine—Dizziness—Thiotepa—sarcoma	0.000396	0.00228	CcSEcCtD
Mexiletine—SCN5A—Cardiac Progenitor Differentiation—KIT—sarcoma	0.000396	0.00886	CbGpPWpGaD
Mexiletine—Dysphagia—Doxorubicin—sarcoma	0.000393	0.00226	CcSEcCtD
Mexiletine—Hypersensitivity—Vincristine—sarcoma	0.000391	0.00225	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.000391	0.00874	CbGpPWpGaD
Mexiletine—Paraesthesia—Etoposide—sarcoma	0.000386	0.00222	CcSEcCtD
Mexiletine—Pancreatitis—Doxorubicin—sarcoma	0.000385	0.00221	CcSEcCtD
Mexiletine—Dyspnoea—Etoposide—sarcoma	0.000384	0.00221	CcSEcCtD
Mexiletine—Somnolence—Etoposide—sarcoma	0.000383	0.0022	CcSEcCtD
Mexiletine—Angina pectoris—Doxorubicin—sarcoma	0.000382	0.0022	CcSEcCtD
Mexiletine—Hypersensitivity—Mitoxantrone—sarcoma	0.000381	0.00219	CcSEcCtD
Mexiletine—Asthenia—Vincristine—sarcoma	0.000381	0.00219	CcSEcCtD
Mexiletine—Vomiting—Thiotepa—sarcoma	0.000381	0.00219	CcSEcCtD
Mexiletine—SCN9A—testis—sarcoma	0.000379	0.0322	CbGeAlD
Mexiletine—Drowsiness—Epirubicin—sarcoma	0.000378	0.00218	CcSEcCtD
Mexiletine—Vomiting—Dactinomycin—sarcoma	0.000378	0.00218	CcSEcCtD
Mexiletine—Rash—Thiotepa—sarcoma	0.000378	0.00217	CcSEcCtD
Mexiletine—Dermatitis—Thiotepa—sarcoma	0.000377	0.00217	CcSEcCtD
Mexiletine—Headache—Thiotepa—sarcoma	0.000375	0.00216	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000375	0.00216	CcSEcCtD
Mexiletine—Rash—Dactinomycin—sarcoma	0.000375	0.00216	CcSEcCtD
Mexiletine—Asthenia—Mitoxantrone—sarcoma	0.000371	0.00214	CcSEcCtD
Mexiletine—Fatigue—Etoposide—sarcoma	0.000371	0.00214	CcSEcCtD
Mexiletine—SCN10A—lymphoid tissue—sarcoma	0.000371	0.0315	CbGeAlD
Mexiletine—AHR—testis—sarcoma	0.00037	0.0314	CbGeAlD
Mexiletine—Pain—Etoposide—sarcoma	0.000368	0.00212	CcSEcCtD
Mexiletine—Constipation—Etoposide—sarcoma	0.000368	0.00212	CcSEcCtD
Mexiletine—Neutropenia—Doxorubicin—sarcoma	0.000367	0.00211	CcSEcCtD
Mexiletine—Diarrhoea—Vincristine—sarcoma	0.000364	0.00209	CcSEcCtD
Mexiletine—SCN5A—cardiac atrium—sarcoma	0.000363	0.0309	CbGeAlD
Mexiletine—Nausea—Thiotepa—sarcoma	0.000356	0.00205	CcSEcCtD
Mexiletine—Feeling abnormal—Etoposide—sarcoma	0.000355	0.00204	CcSEcCtD
Mexiletine—Diarrhoea—Mitoxantrone—sarcoma	0.000354	0.00204	CcSEcCtD
Mexiletine—Nausea—Dactinomycin—sarcoma	0.000353	0.00203	CcSEcCtD
Mexiletine—Agranulocytosis—Epirubicin—sarcoma	0.000353	0.00203	CcSEcCtD
Mexiletine—Gastrointestinal pain—Etoposide—sarcoma	0.000352	0.00203	CcSEcCtD
Mexiletine—Dizziness—Vincristine—sarcoma	0.000351	0.00202	CcSEcCtD
Mexiletine—Drowsiness—Doxorubicin—sarcoma	0.00035	0.00201	CcSEcCtD
Mexiletine—AHR—liver—sarcoma	0.000349	0.0297	CbGeAlD
Mexiletine—CYP2B6—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000349	0.0078	CbGpPWpGaD
Mexiletine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000347	0.002	CcSEcCtD
Mexiletine—Bradycardia—Epirubicin—sarcoma	0.000346	0.00199	CcSEcCtD
Mexiletine—SCN9A—Developmental Biology—EZR—sarcoma	0.000342	0.00765	CbGpPWpGaD
Mexiletine—Abdominal pain—Etoposide—sarcoma	0.00034	0.00196	CcSEcCtD
Mexiletine—Body temperature increased—Etoposide—sarcoma	0.00034	0.00196	CcSEcCtD
Mexiletine—Hepatitis—Epirubicin—sarcoma	0.00034	0.00195	CcSEcCtD
Mexiletine—SCN4A—testis—sarcoma	0.000338	0.0287	CbGeAlD
Mexiletine—Hypoaesthesia—Epirubicin—sarcoma	0.000338	0.00194	CcSEcCtD
Mexiletine—Vomiting—Vincristine—sarcoma	0.000338	0.00194	CcSEcCtD
Mexiletine—Pharyngitis—Epirubicin—sarcoma	0.000337	0.00194	CcSEcCtD
Mexiletine—Rash—Vincristine—sarcoma	0.000335	0.00193	CcSEcCtD
Mexiletine—Dermatitis—Vincristine—sarcoma	0.000335	0.00193	CcSEcCtD
Mexiletine—Headache—Vincristine—sarcoma	0.000333	0.00192	CcSEcCtD
Mexiletine—Vomiting—Mitoxantrone—sarcoma	0.000329	0.00189	CcSEcCtD
Mexiletine—Visual impairment—Epirubicin—sarcoma	0.000327	0.00188	CcSEcCtD
Mexiletine—Agranulocytosis—Doxorubicin—sarcoma	0.000327	0.00188	CcSEcCtD
Mexiletine—Rash—Mitoxantrone—sarcoma	0.000326	0.00188	CcSEcCtD
Mexiletine—Dermatitis—Mitoxantrone—sarcoma	0.000326	0.00188	CcSEcCtD
Mexiletine—Headache—Mitoxantrone—sarcoma	0.000324	0.00187	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—MDM2—sarcoma	0.000323	0.00723	CbGpPWpGaD
Mexiletine—Erythema multiforme—Epirubicin—sarcoma	0.000321	0.00185	CcSEcCtD
Mexiletine—Bradycardia—Doxorubicin—sarcoma	0.00032	0.00184	CcSEcCtD
Mexiletine—Hypersensitivity—Etoposide—sarcoma	0.000317	0.00182	CcSEcCtD
Mexiletine—Tinnitus—Epirubicin—sarcoma	0.000317	0.00182	CcSEcCtD
Mexiletine—Nausea—Vincristine—sarcoma	0.000316	0.00182	CcSEcCtD
Mexiletine—AHR—Adipogenesis—CTNNB1—sarcoma	0.000314	0.00703	CbGpPWpGaD
Mexiletine—Hepatitis—Doxorubicin—sarcoma	0.000314	0.00181	CcSEcCtD
Mexiletine—SCN2A—Developmental Biology—EZR—sarcoma	0.000314	0.00703	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—EZR—sarcoma	0.000314	0.00703	CbGpPWpGaD
Mexiletine—Hypoaesthesia—Doxorubicin—sarcoma	0.000313	0.0018	CcSEcCtD
Mexiletine—Pharyngitis—Doxorubicin—sarcoma	0.000312	0.00179	CcSEcCtD
Mexiletine—AHR—Circadian rythm related genes—CREB1—sarcoma	0.000311	0.00696	CbGpPWpGaD
Mexiletine—Asthenia—Etoposide—sarcoma	0.000309	0.00178	CcSEcCtD
Mexiletine—Nausea—Mitoxantrone—sarcoma	0.000307	0.00177	CcSEcCtD
Mexiletine—Arrhythmia—Epirubicin—sarcoma	0.000303	0.00175	CcSEcCtD
Mexiletine—SCN10A—Developmental Biology—EZR—sarcoma	0.000303	0.00678	CbGpPWpGaD
Mexiletine—Visual impairment—Doxorubicin—sarcoma	0.000303	0.00174	CcSEcCtD
Mexiletine—Alopecia—Epirubicin—sarcoma	0.0003	0.00173	CcSEcCtD
Mexiletine—SCN5A—Axon guidance—EZR—sarcoma	0.000298	0.00668	CbGpPWpGaD
Mexiletine—Erythema multiforme—Doxorubicin—sarcoma	0.000297	0.00171	CcSEcCtD
Mexiletine—Diarrhoea—Etoposide—sarcoma	0.000294	0.00169	CcSEcCtD
Mexiletine—Tinnitus—Doxorubicin—sarcoma	0.000293	0.00169	CcSEcCtD
Mexiletine—Tension—Epirubicin—sarcoma	0.00029	0.00167	CcSEcCtD
Mexiletine—Dysgeusia—Epirubicin—sarcoma	0.00029	0.00167	CcSEcCtD
Mexiletine—Nervousness—Epirubicin—sarcoma	0.000287	0.00165	CcSEcCtD
Mexiletine—Dizziness—Etoposide—sarcoma	0.000285	0.00164	CcSEcCtD
Mexiletine—Muscle spasms—Epirubicin—sarcoma	0.000284	0.00164	CcSEcCtD
Mexiletine—SCN9A—Axon guidance—PTPRC—sarcoma	0.000282	0.00632	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—CCND1—sarcoma	0.000282	0.0063	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—JUN—sarcoma	0.000281	0.00629	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—MYOG—sarcoma	0.000281	0.00629	CbGpPWpGaD
Mexiletine—Arrhythmia—Doxorubicin—sarcoma	0.000281	0.00162	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	0.000279	0.00624	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—MYOD1—sarcoma	0.000279	0.00623	CbGpPWpGaD
Mexiletine—Vision blurred—Epirubicin—sarcoma	0.000279	0.0016	CcSEcCtD
Mexiletine—Alopecia—Doxorubicin—sarcoma	0.000278	0.0016	CcSEcCtD
Mexiletine—SCN9A—Axon guidance—PLCG1—sarcoma	0.000276	0.00618	CbGpPWpGaD
Mexiletine—SCN9A—lymph node—sarcoma	0.000275	0.0233	CbGeAlD
Mexiletine—Ill-defined disorder—Epirubicin—sarcoma	0.000274	0.00158	CcSEcCtD
Mexiletine—Vomiting—Etoposide—sarcoma	0.000274	0.00157	CcSEcCtD
Mexiletine—Rash—Etoposide—sarcoma	0.000271	0.00156	CcSEcCtD
Mexiletine—Dermatitis—Etoposide—sarcoma	0.000271	0.00156	CcSEcCtD
Mexiletine—Headache—Etoposide—sarcoma	0.00027	0.00155	CcSEcCtD
Mexiletine—Tension—Doxorubicin—sarcoma	0.000268	0.00154	CcSEcCtD
Mexiletine—AHR—lymph node—sarcoma	0.000268	0.0228	CbGeAlD
Mexiletine—Dysgeusia—Doxorubicin—sarcoma	0.000268	0.00154	CcSEcCtD
Mexiletine—Malaise—Epirubicin—sarcoma	0.000267	0.00153	CcSEcCtD
Mexiletine—Nervousness—Doxorubicin—sarcoma	0.000266	0.00153	CcSEcCtD
Mexiletine—Syncope—Epirubicin—sarcoma	0.000265	0.00153	CcSEcCtD
Mexiletine—Leukopenia—Epirubicin—sarcoma	0.000265	0.00152	CcSEcCtD
Mexiletine—Muscle spasms—Doxorubicin—sarcoma	0.000263	0.00151	CcSEcCtD
Mexiletine—CYP2D6—Melatonin metabolism and effects—FOXO1—sarcoma	0.000262	0.00587	CbGpPWpGaD
Mexiletine—Palpitations—Epirubicin—sarcoma	0.000261	0.0015	CcSEcCtD
Mexiletine—Loss of consciousness—Epirubicin—sarcoma	0.00026	0.0015	CcSEcCtD
Mexiletine—SCN4A—Axon guidance—PTPRC—sarcoma	0.000259	0.0058	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—PTPRC—sarcoma	0.000259	0.0058	CbGpPWpGaD
Mexiletine—Vision blurred—Doxorubicin—sarcoma	0.000258	0.00148	CcSEcCtD
Mexiletine—Convulsion—Epirubicin—sarcoma	0.000256	0.00147	CcSEcCtD
Mexiletine—SCN4A—Developmental Biology—MYOD1—sarcoma	0.000256	0.00573	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—MYOD1—sarcoma	0.000256	0.00573	CbGpPWpGaD
Mexiletine—Nausea—Etoposide—sarcoma	0.000256	0.00147	CcSEcCtD
Mexiletine—Hypertension—Epirubicin—sarcoma	0.000255	0.00147	CcSEcCtD
Mexiletine—SCN4A—Axon guidance—PLCG1—sarcoma	0.000254	0.00568	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—PLCG1—sarcoma	0.000254	0.00568	CbGpPWpGaD
Mexiletine—Ill-defined disorder—Doxorubicin—sarcoma	0.000254	0.00146	CcSEcCtD
Mexiletine—CYP1A2—hematopoietic system—sarcoma	0.000252	0.0214	CbGeAlD
Mexiletine—Chest pain—Epirubicin—sarcoma	0.000252	0.00145	CcSEcCtD
Mexiletine—Arthralgia—Epirubicin—sarcoma	0.000252	0.00145	CcSEcCtD
Mexiletine—SCN10A—Axon guidance—PTPRC—sarcoma	0.00025	0.0056	CbGpPWpGaD
Mexiletine—Discomfort—Epirubicin—sarcoma	0.000249	0.00143	CcSEcCtD
Mexiletine—SCN10A—Developmental Biology—MYOD1—sarcoma	0.000247	0.00552	CbGpPWpGaD
Mexiletine—Malaise—Doxorubicin—sarcoma	0.000247	0.00142	CcSEcCtD
Mexiletine—Dry mouth—Epirubicin—sarcoma	0.000246	0.00142	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—VEGFA—sarcoma	0.000246	0.00549	CbGpPWpGaD
Mexiletine—Syncope—Doxorubicin—sarcoma	0.000245	0.00141	CcSEcCtD
Mexiletine—SCN10A—Axon guidance—PLCG1—sarcoma	0.000245	0.00548	CbGpPWpGaD
Mexiletine—Leukopenia—Doxorubicin—sarcoma	0.000245	0.00141	CcSEcCtD
Mexiletine—Confusional state—Epirubicin—sarcoma	0.000243	0.0014	CcSEcCtD
Mexiletine—SCN9A—L1CAM interactions—SRC—sarcoma	0.000243	0.00543	CbGpPWpGaD
Mexiletine—Palpitations—Doxorubicin—sarcoma	0.000242	0.00139	CcSEcCtD
Mexiletine—CYP2B6—hematopoietic system—sarcoma	0.000241	0.0205	CbGeAlD
Mexiletine—Oedema—Epirubicin—sarcoma	0.000241	0.00139	CcSEcCtD
Mexiletine—Loss of consciousness—Doxorubicin—sarcoma	0.00024	0.00138	CcSEcCtD
Mexiletine—CYP2E1—seminal vesicle—sarcoma	0.000238	0.0203	CbGeAlD
Mexiletine—Shock—Epirubicin—sarcoma	0.000237	0.00137	CcSEcCtD
Mexiletine—Convulsion—Doxorubicin—sarcoma	0.000237	0.00136	CcSEcCtD
Mexiletine—Thrombocytopenia—Epirubicin—sarcoma	0.000236	0.00136	CcSEcCtD
Mexiletine—Hypertension—Doxorubicin—sarcoma	0.000236	0.00136	CcSEcCtD
Mexiletine—Hyperhidrosis—Epirubicin—sarcoma	0.000233	0.00134	CcSEcCtD
Mexiletine—Chest pain—Doxorubicin—sarcoma	0.000233	0.00134	CcSEcCtD
Mexiletine—Arthralgia—Doxorubicin—sarcoma	0.000233	0.00134	CcSEcCtD
Mexiletine—Discomfort—Doxorubicin—sarcoma	0.00023	0.00132	CcSEcCtD
Mexiletine—Dry mouth—Doxorubicin—sarcoma	0.000228	0.00131	CcSEcCtD
Mexiletine—CYP2E1—hematopoietic system—sarcoma	0.000227	0.0192	CbGeAlD
Mexiletine—AHR—Integrated Breast Cancer Pathway—MYC—sarcoma	0.000226	0.00505	CbGpPWpGaD
Mexiletine—Hypotension—Epirubicin—sarcoma	0.000225	0.0013	CcSEcCtD
Mexiletine—Confusional state—Doxorubicin—sarcoma	0.000225	0.0013	CcSEcCtD
Mexiletine—AHR—Circadian rythm related genes—JUN—sarcoma	0.000224	0.005	CbGpPWpGaD
Mexiletine—Oedema—Doxorubicin—sarcoma	0.000223	0.00128	CcSEcCtD
Mexiletine—SCN4A—L1CAM interactions—SRC—sarcoma	0.000223	0.00499	CbGpPWpGaD
Mexiletine—SCN2A—L1CAM interactions—SRC—sarcoma	0.000223	0.00499	CbGpPWpGaD
Mexiletine—CYP1A2—Melatonin metabolism and effects—FOXO1—sarcoma	0.000222	0.00497	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.000221	0.00494	CbGpPWpGaD
Mexiletine—CYP1A2—Estrogen Receptor Pathway—JUN—sarcoma	0.00022	0.00493	CbGpPWpGaD
Mexiletine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00022	0.00126	CcSEcCtD
Mexiletine—Shock—Doxorubicin—sarcoma	0.00022	0.00126	CcSEcCtD
Mexiletine—Thrombocytopenia—Doxorubicin—sarcoma	0.000219	0.00126	CcSEcCtD
Mexiletine—Paraesthesia—Epirubicin—sarcoma	0.000217	0.00125	CcSEcCtD
Mexiletine—Hyperhidrosis—Doxorubicin—sarcoma	0.000216	0.00124	CcSEcCtD
Mexiletine—SCN10A—L1CAM interactions—SRC—sarcoma	0.000215	0.00481	CbGpPWpGaD
Mexiletine—Dyspnoea—Epirubicin—sarcoma	0.000215	0.00124	CcSEcCtD
Mexiletine—Somnolence—Epirubicin—sarcoma	0.000214	0.00123	CcSEcCtD
Mexiletine—SCN5A—Developmental Biology—EZR—sarcoma	0.000213	0.00476	CbGpPWpGaD
Mexiletine—SCN9A—L1CAM interactions—EGFR—sarcoma	0.000213	0.00476	CbGpPWpGaD
Mexiletine—Dyspepsia—Epirubicin—sarcoma	0.000212	0.00122	CcSEcCtD
Mexiletine—CYP2B6—skin of body—sarcoma	0.00021	0.0178	CbGeAlD
Mexiletine—SCN10A—lymph node—sarcoma	0.000209	0.0178	CbGeAlD
Mexiletine—AHR—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.000209	0.00467	CbGpPWpGaD
Mexiletine—Hypotension—Doxorubicin—sarcoma	0.000209	0.0012	CcSEcCtD
Mexiletine—Fatigue—Epirubicin—sarcoma	0.000208	0.0012	CcSEcCtD
Mexiletine—Pain—Epirubicin—sarcoma	0.000206	0.00119	CcSEcCtD
Mexiletine—Constipation—Epirubicin—sarcoma	0.000206	0.00119	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000203	0.00117	CcSEcCtD
Mexiletine—SCN9A—Developmental Biology—PTPRC—sarcoma	0.000202	0.00451	CbGpPWpGaD
Mexiletine—Paraesthesia—Doxorubicin—sarcoma	0.0002	0.00115	CcSEcCtD
Mexiletine—Dyspnoea—Doxorubicin—sarcoma	0.000199	0.00115	CcSEcCtD
Mexiletine—Feeling abnormal—Epirubicin—sarcoma	0.000199	0.00114	CcSEcCtD
Mexiletine—Somnolence—Doxorubicin—sarcoma	0.000198	0.00114	CcSEcCtD
Mexiletine—Gastrointestinal pain—Epirubicin—sarcoma	0.000197	0.00114	CcSEcCtD
Mexiletine—SCN9A—Developmental Biology—PLCG1—sarcoma	0.000197	0.00441	CbGpPWpGaD
Mexiletine—Dyspepsia—Doxorubicin—sarcoma	0.000197	0.00113	CcSEcCtD
Mexiletine—SCN4A—L1CAM interactions—EGFR—sarcoma	0.000196	0.00437	CbGpPWpGaD
Mexiletine—SCN2A—L1CAM interactions—EGFR—sarcoma	0.000196	0.00437	CbGpPWpGaD
Mexiletine—Fatigue—Doxorubicin—sarcoma	0.000192	0.00111	CcSEcCtD
Mexiletine—Constipation—Doxorubicin—sarcoma	0.000191	0.0011	CcSEcCtD
Mexiletine—Pain—Doxorubicin—sarcoma	0.000191	0.0011	CcSEcCtD
Mexiletine—Body temperature increased—Epirubicin—sarcoma	0.000191	0.0011	CcSEcCtD
Mexiletine—Abdominal pain—Epirubicin—sarcoma	0.000191	0.0011	CcSEcCtD
Mexiletine—SCN10A—L1CAM interactions—EGFR—sarcoma	0.000189	0.00422	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—TP53—sarcoma	0.000186	0.00415	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—PTPRC—sarcoma	0.000185	0.00414	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—PTPRC—sarcoma	0.000185	0.00414	CbGpPWpGaD
Mexiletine—Feeling abnormal—Doxorubicin—sarcoma	0.000184	0.00106	CcSEcCtD
Mexiletine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000183	0.00105	CcSEcCtD
Mexiletine—CYP3A4—hematopoietic system—sarcoma	0.000182	0.0155	CbGeAlD
Mexiletine—SCN4A—Developmental Biology—PLCG1—sarcoma	0.000181	0.00405	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—PLCG1—sarcoma	0.000181	0.00405	CbGpPWpGaD
Mexiletine—CYP2D6—hematopoietic system—sarcoma	0.000179	0.0152	CbGeAlD
Mexiletine—SCN10A—Developmental Biology—PTPRC—sarcoma	0.000179	0.00399	CbGpPWpGaD
Mexiletine—Hypersensitivity—Epirubicin—sarcoma	0.000178	0.00102	CcSEcCtD
Mexiletine—Abdominal pain—Doxorubicin—sarcoma	0.000176	0.00102	CcSEcCtD
Mexiletine—Body temperature increased—Doxorubicin—sarcoma	0.000176	0.00102	CcSEcCtD
Mexiletine—SCN5A—Axon guidance—PTPRC—sarcoma	0.000176	0.00394	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—PLCG1—sarcoma	0.000175	0.00391	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—MYOD1—sarcoma	0.000174	0.00388	CbGpPWpGaD
Mexiletine—Asthenia—Epirubicin—sarcoma	0.000173	0.000996	CcSEcCtD
Mexiletine—SCN5A—Axon guidance—PLCG1—sarcoma	0.000172	0.00385	CbGpPWpGaD
Mexiletine—CYP2B6—lymphoid tissue—sarcoma	0.00017	0.0144	CbGeAlD
Mexiletine—Diarrhoea—Epirubicin—sarcoma	0.000165	0.00095	CcSEcCtD
Mexiletine—Hypersensitivity—Doxorubicin—sarcoma	0.000164	0.000946	CcSEcCtD
Mexiletine—SCN9A—Axon guidance—KDR—sarcoma	0.000162	0.00363	CbGpPWpGaD
Mexiletine—Asthenia—Doxorubicin—sarcoma	0.00016	0.000922	CcSEcCtD
Mexiletine—Dizziness—Epirubicin—sarcoma	0.00016	0.000918	CcSEcCtD
Mexiletine—CYP2E1—lymphoid tissue—sarcoma	0.000159	0.0135	CbGeAlD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000159	0.00356	CbGpPWpGaD
Mexiletine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000158	0.00355	CbGpPWpGaD
Mexiletine—Vomiting—Epirubicin—sarcoma	0.000153	0.000883	CcSEcCtD
Mexiletine—CYP2E1—Tryptophan metabolism—MDM2—sarcoma	0.000153	0.00343	CbGpPWpGaD
Mexiletine—Diarrhoea—Doxorubicin—sarcoma	0.000153	0.000879	CcSEcCtD
Mexiletine—Rash—Epirubicin—sarcoma	0.000152	0.000875	CcSEcCtD
Mexiletine—Dermatitis—Epirubicin—sarcoma	0.000152	0.000875	CcSEcCtD
Mexiletine—SCN5A—L1CAM interactions—SRC—sarcoma	0.000151	0.00338	CbGpPWpGaD
Mexiletine—Headache—Epirubicin—sarcoma	0.000151	0.00087	CcSEcCtD
Mexiletine—CYP2E1—tendon—sarcoma	0.00015	0.0127	CbGeAlD
Mexiletine—SCN2A—Axon guidance—KDR—sarcoma	0.000149	0.00333	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—KDR—sarcoma	0.000149	0.00333	CbGpPWpGaD
Mexiletine—Dizziness—Doxorubicin—sarcoma	0.000148	0.000849	CcSEcCtD
Mexiletine—AHR—Circadian rythm related genes—TP53—sarcoma	0.000148	0.0033	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—KDR—sarcoma	0.000144	0.00321	CbGpPWpGaD
Mexiletine—Nausea—Epirubicin—sarcoma	0.000143	0.000825	CcSEcCtD
Mexiletine—SCN9A—Axon guidance—CREB1—sarcoma	0.000142	0.00318	CbGpPWpGaD
Mexiletine—Vomiting—Doxorubicin—sarcoma	0.000142	0.000817	CcSEcCtD
Mexiletine—Rash—Doxorubicin—sarcoma	0.000141	0.00081	CcSEcCtD
Mexiletine—Dermatitis—Doxorubicin—sarcoma	0.000141	0.000809	CcSEcCtD
Mexiletine—SCN9A—Developmental Biology—FOXO1—sarcoma	0.00014	0.00313	CbGpPWpGaD
Mexiletine—Headache—Doxorubicin—sarcoma	0.00014	0.000805	CcSEcCtD
Mexiletine—Nausea—Doxorubicin—sarcoma	0.000133	0.000763	CcSEcCtD
Mexiletine—SCN5A—L1CAM interactions—EGFR—sarcoma	0.000133	0.00297	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—MMP2—sarcoma	0.000132	0.00296	CbGpPWpGaD
Mexiletine—CYP2B6—testis—sarcoma	0.000132	0.0112	CbGeAlD
Mexiletine—SCN2A—Axon guidance—CREB1—sarcoma	0.000131	0.00292	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—CREB1—sarcoma	0.000131	0.00292	CbGpPWpGaD
Mexiletine—CYP1A2—liver—sarcoma	0.00013	0.0111	CbGeAlD
Mexiletine—SCN4A—Developmental Biology—FOXO1—sarcoma	0.000129	0.00288	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—FOXO1—sarcoma	0.000129	0.00288	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—CREB1—sarcoma	0.000126	0.00282	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—PTPRC—sarcoma	0.000126	0.00281	CbGpPWpGaD
Mexiletine—CYP2B6—liver—sarcoma	0.000125	0.0106	CbGeAlD
Mexiletine—CYP2E1—testis—sarcoma	0.000124	0.0105	CbGeAlD
Mexiletine—SCN10A—Developmental Biology—FOXO1—sarcoma	0.000124	0.00277	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—PLCG1—sarcoma	0.000123	0.00275	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—MMP2—sarcoma	0.000122	0.00272	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—MMP2—sarcoma	0.000122	0.00272	CbGpPWpGaD
Mexiletine—CYP2E1—liver—sarcoma	0.000117	0.00997	CbGeAlD
Mexiletine—SCN10A—Axon guidance—MMP2—sarcoma	0.000117	0.00262	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—KDR—sarcoma	0.000116	0.00259	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—JUN—sarcoma	0.000114	0.00256	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000113	0.00254	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—KDR—sarcoma	0.000106	0.00238	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—KDR—sarcoma	0.000106	0.00238	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—KDR—sarcoma	0.000103	0.00229	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—CREB1—sarcoma	0.000101	0.00227	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—KDR—sarcoma	0.000101	0.00226	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—VEGFA—sarcoma	9.99e-05	0.00223	CbGpPWpGaD
Mexiletine—CYP2D6—testis—sarcoma	9.83e-05	0.00835	CbGeAlD
Mexiletine—SCN9A—Developmental Biology—MMP2—sarcoma	9.45e-05	0.00211	CbGpPWpGaD
Mexiletine—CYP3A4—liver—sarcoma	9.44e-05	0.00802	CbGeAlD
Mexiletine—SCN2A—Developmental Biology—CREB1—sarcoma	9.33e-05	0.00209	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—CREB1—sarcoma	9.33e-05	0.00209	CbGpPWpGaD
Mexiletine—CYP2D6—liver—sarcoma	9.29e-05	0.0079	CbGeAlD
Mexiletine—CYP1A2—Tryptophan metabolism—MDM2—sarcoma	9.22e-05	0.00206	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—SRC—sarcoma	9.17e-05	0.00205	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—CREB1—sarcoma	8.99e-05	0.00201	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—VEGFA—sarcoma	8.94e-05	0.002	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—CREB1—sarcoma	8.86e-05	0.00198	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—NRAS—sarcoma	8.83e-05	0.00197	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—FOXO1—sarcoma	8.72e-05	0.00195	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—MMP2—sarcoma	8.68e-05	0.00194	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—MMP2—sarcoma	8.68e-05	0.00194	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—SRC—sarcoma	8.43e-05	0.00189	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—SRC—sarcoma	8.43e-05	0.00189	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—MMP2—sarcoma	8.37e-05	0.00187	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—MMP2—sarcoma	8.25e-05	0.00184	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	8.24e-05	0.00184	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—VEGFA—sarcoma	8.21e-05	0.00184	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—VEGFA—sarcoma	8.21e-05	0.00184	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—SRC—sarcoma	8.13e-05	0.00182	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—NRAS—sarcoma	8.11e-05	0.00181	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—NRAS—sarcoma	8.11e-05	0.00181	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—EGFR—sarcoma	8.04e-05	0.0018	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	8.01e-05	0.00179	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—VEGFA—sarcoma	7.92e-05	0.00177	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—NRAS—sarcoma	7.82e-05	0.00175	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—KRAS—sarcoma	7.6e-05	0.0017	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—EGFR—sarcoma	7.39e-05	0.00165	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—EGFR—sarcoma	7.39e-05	0.00165	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—CTNNB1—sarcoma	7.24e-05	0.00162	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—KDR—sarcoma	7.21e-05	0.00161	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	7.19e-05	0.00161	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	7.19e-05	0.00161	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—EGFR—sarcoma	7.13e-05	0.00159	CbGpPWpGaD
Mexiletine—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	7.11e-05	0.00159	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	7e-05	0.00157	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—KRAS—sarcoma	6.98e-05	0.00156	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—KRAS—sarcoma	6.98e-05	0.00156	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	6.91e-05	0.00155	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—KRAS—sarcoma	6.73e-05	0.00151	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—CTNNB1—sarcoma	6.66e-05	0.00149	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—CTNNB1—sarcoma	6.66e-05	0.00149	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—SRC—sarcoma	6.55e-05	0.00146	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—HRAS—sarcoma	6.46e-05	0.00144	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	6.44e-05	0.00144	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—CTNNB1—sarcoma	6.42e-05	0.00144	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—VEGFA—sarcoma	6.38e-05	0.00143	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—CREB1—sarcoma	6.32e-05	0.00141	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	6.3e-05	0.00141	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	6.3e-05	0.00141	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—NRAS—sarcoma	6.3e-05	0.00141	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—SRC—sarcoma	6.02e-05	0.00135	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—SRC—sarcoma	6.02e-05	0.00135	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	5.95e-05	0.00133	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—HRAS—sarcoma	5.93e-05	0.00133	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—HRAS—sarcoma	5.93e-05	0.00133	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—MMP2—sarcoma	5.89e-05	0.00132	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—VEGFA—sarcoma	5.86e-05	0.00131	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—VEGFA—sarcoma	5.86e-05	0.00131	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—SRC—sarcoma	5.8e-05	0.0013	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—NRAS—sarcoma	5.79e-05	0.00129	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—NRAS—sarcoma	5.79e-05	0.00129	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—EGFR—sarcoma	5.74e-05	0.00128	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—HRAS—sarcoma	5.72e-05	0.00128	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—SRC—sarcoma	5.72e-05	0.00128	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—VEGFA—sarcoma	5.65e-05	0.00126	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—NRAS—sarcoma	5.58e-05	0.00125	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—VEGFA—sarcoma	5.57e-05	0.00125	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—NRAS—sarcoma	5.5e-05	0.00123	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—KRAS—sarcoma	5.42e-05	0.00121	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—EGFR—sarcoma	5.27e-05	0.00118	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—EGFR—sarcoma	5.27e-05	0.00118	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—EGFR—sarcoma	5.08e-05	0.00114	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	5.06e-05	0.00113	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—EGFR—sarcoma	5.01e-05	0.00112	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—KRAS—sarcoma	4.98e-05	0.00111	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—KRAS—sarcoma	4.98e-05	0.00111	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—KRAS—sarcoma	4.8e-05	0.00107	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—KRAS—sarcoma	4.73e-05	0.00106	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—HRAS—sarcoma	4.61e-05	0.00103	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—CTNNB1—sarcoma	4.51e-05	0.00101	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—HRAS—sarcoma	4.23e-05	0.000947	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—HRAS—sarcoma	4.23e-05	0.000947	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—HRAS—sarcoma	4.08e-05	0.000913	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—SRC—sarcoma	4.08e-05	0.000912	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—HRAS—sarcoma	4.02e-05	0.0009	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—VEGFA—sarcoma	3.97e-05	0.000889	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—NRAS—sarcoma	3.92e-05	0.000878	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—EGFR—sarcoma	3.57e-05	0.0008	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—KRAS—sarcoma	3.38e-05	0.000755	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—HRAS—sarcoma	2.87e-05	0.000642	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ENO2—sarcoma	2.58e-05	0.000577	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—HBA1—sarcoma	2.56e-05	0.000574	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ENO2—sarcoma	2.53e-05	0.000565	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—HBA1—sarcoma	2.51e-05	0.000562	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PLCG1—sarcoma	2.19e-05	0.00049	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PLCG1—sarcoma	2.14e-05	0.00048	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ENO2—sarcoma	1.79e-05	0.000401	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—HBA1—sarcoma	1.78e-05	0.000399	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PLCG1—sarcoma	1.52e-05	0.00034	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ENO2—sarcoma	1.52e-05	0.00034	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—HBA1—sarcoma	1.51e-05	0.000338	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PLCG1—sarcoma	1.29e-05	0.000288	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ENO2—sarcoma	1.17e-05	0.000262	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HBA1—sarcoma	1.17e-05	0.000261	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PLCG1—sarcoma	9.95e-06	0.000223	CbGpPWpGaD
